Suchen Sie nach Informationen zu Unternehmenszentrale Rübenkamp 226? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.asklepios.com/konzern/unternehmen/impressum/
Rübenkamp 226. 22307 Hamburg. Kontakt. Tel.: (0 40) 18 18-82 66 96. Fax: (0 40) 18 18-82 67 99. [email protected]. Gesetzliche Vertreter Persönlich haftende Gesellschafterin. Asklepios Kliniken Management GmbH. Sitz der Gesellschaft: Königstein im Taunus, Registergericht: AG Königstein im Taunus HRB 9737.
https://www.asklepios.com/hamburg/personalservice/impressum/
Rübenkamp 226 22307 Hamburg. Kontakt. Tel.: (0 40) 18 18-80 68 10 Fax: (0 40) 18 18-70 68 10. [email protected]. Gesetzliche Vertreter. Geschäftsführer Asklepios Kliniken Hamburg GmbH: Joachim Gemmel (Sprecher), Prof. Dr. Christoph U. Herborn, Anja Rhode;
https://www.yelp.com/biz/asklepios-hamburg-8
Asklepios in Hamburg, reviews by real people. Yelp is a fun and easy way to find, recommend and talk about what’s great and not so great in Hamburg and beyond.
https://idw-online.de/en/institution586
Rübenkamp 226 22307 Hamburg Germany Hamburg email address: [email protected]. Dr.med. Franz Jürgen Schell Medizinischer Pressesprecher Telephone: 040 / 1818 8266 - 31
https://www.kompany.ie/p/de/vr16845%20hamburg
Rübenkamp 226, 22307 Hamburg DE Phone Number -Country Germany Court DE/Hamburg Incorporated 2001-02-26 Type of Business eingetragener Verein Share Capital 0,00 Age Of Company 2001-02-26 20 years 0-2; 3-5; 6-20; 21-50; 51+ years; Company Description Unterstützungskasse Asklepios Kliniken Hamburg e.V. ...
https://opencorporates.com/companies/de/K1101R_HRB100724
Rübenkamp 226, 22307 Hamburg. Germany; Directors / Officers. Deniz Doctor Cansun-Labenski, geschäftsführer, 28 Jan 2019 - Markus Stobbe, geschäftsführer, 18 Apr 2017 - Thomas Doctor Wolfram, geschäftsführer, 8 Oct 2013 - Inactive Directors / Officers. Achim Doctor Rogge, geschäftsführer, - 21 Apr 2009
https://www.northdata.com/?id=3741925758
Rübenkamp 226, 22307 Hamburg. The object of the company is the management, acquisition and operation of hospitals. Share capital General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing ...
https://gb.kompass.com/c/asklepios-kliniken-gmbh-co-kgaa/de698954/
Login Welcome to Kompass Global B2B portal where Buyers can find and contact the best product or service Suppliers! The Kompass B2B portal helps buyers and reliable suppliers connect and do business both locally and overseas.
https://www.sciencedirect.com/science/article/abs/pii/S0090825813001108
The aim of this study is to evaluate the activity and toxicity of fulvestrant, a pure estrogen receptor antagonist in patients with advanced or recurr…
https://www.sciencedirect.com/science/article/pii/S0090825813001108
Methods. Eligible patients with advanced or recurrent endometrial cancer not amenable to curative surgery and/or radiotherapy were treated with fulvestrant at a dose of 250 mg by IM injection every 4 weeks for at least 12 weeks.Therapy was continued until disease progression, death, intolerable side effects or end of study.
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Unternehmenszentrale Rübenkamp 226 gefunden haben.
